Section Arrow
Quote
ELOX.NASDAQ
- Eloxx Pharmaceuticals Inc
Quotes are at least 15-min delayed:2026/06/10 11:59 EDT
Regular Hours
Last
 10
-1.01 (-9.17%)
Day High 
10 
Prev. Close
11.01 
1-M High
11.6 
Volume 
49.07K 
Bid
9.51
Ask
9.99
Day Low
8.2 
Open
10 
1-M Low
0.0231 
Market Cap 
19.49M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 5.49 
20-SMA 3.78 
50-SMA 2.2 
52-W High 11.6 
52-W Low 0.000011 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.12/-8.04
Enterprise Value
19.49M
Balance Sheet
Book Value Per Share
-1.00
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ADTXAditxt Inc.0.0199-0.009-31.14%-- 
GOSSGossamer Bio0.1499-0.0101-6.31%-- 
RXRXRecursion Pharmaceuticals3.0981-0.1219-3.79%-- 
ELABPmgc Holdings Inc1.43+0.02+1.42%-- 
GERNGeron Corp1.115-0.005-0.45%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.